Last reviewed · How we verify
Glucosamine sulphate
At a glance
| Generic name | Glucosamine sulphate |
|---|---|
| Also known as | antiarthritis drugs, antiinflammatory drugs, Glucosamine sulfata Pharma Nord, glucosamine from Ferrosan |
| Sponsor | Ferrosan AS |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Combination Gerotherapeutic Interventions for Healthspan Improvement (PHASE3)
- Kinesiological / Dietary Supplement Intervention in Knee Osteoarthritis (NA)
- Oral N-acetylglucosamine in Crohn's Disease (PHASE2)
- A Clinical Study to Evaluate the Efficacy of Native CT-II® in Individuals With Knee Osteoarthritis (NA)
- Effects of UC-II, Glucosamine and Curcumin Supplementation on Knee Pain and Inflammation. (NA)
- Long-Term Effects of Mobithron Advance on Knee Osteoarthritis Aims to Investigate the Effects of Mobithron Advance on OA Progression (EARLY_PHASE1)
- Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial. (PHASE2, PHASE3)
- A Trial of a Multi-Component Nutritional Supplement in Hydrogen-Dominant Small Intestinal Bacterial Overgrowth (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Glucosamine sulphate CI brief — competitive landscape report
- Glucosamine sulphate updates RSS · CI watch RSS
- Ferrosan AS portfolio CI